AI assistant
Sending…
CATALYST PHARMACEUTICALS, INC. — Director's Dealing 2024
Aug 19, 2024
31542_dirs_2024-08-19_1248ad9e-f471-4166-8829-6a2ba6058f9e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CATALYST PHARMACEUTICALS, INC. (CPRX)
CIK: 0001369568
Period of Report: 2024-08-15
Reporting Person: MCENANY PATRICK J (Director, Chairman of Board of Directors)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-08-15 | Common Stock, par value $0.001 per share | G | 45000 | $0.00 | Disposed | 4483269 | Direct |
Footnotes
F1: Represents a charitable gift to the Baptist Health South Florida Foundation for which no compensation was given to the Reporting Person. Reporting Person retains no control over the shares gifted.
More from CATALYST PHARMACEUTICALS, INC.
Regulatory Filings
2026
May 11
Regulatory Filings
2026
May 7
Major Shareholding Notification
2026
Mar 26
Regulatory Filings
2026
Feb 25
Annual Report
2026
Feb 25
Director's Dealing
2026
Feb 19
Regulatory Filings
2026
Jan 12
Director's Dealing
2026
Jan 6
Director's Dealing
2026
Jan 6
Director's Dealing
2025
Dec 30